Total (n = 226)

No COVID-19 (n = 96)

COVID-19 (n = 130)

p-value

SMD

Age (years)

66.9 (14.1)

69.3 (13.6)

65.0 (14.3)

0.02

0.30

Female

66 (29.2)

34 (35.4)

32 (24.6)

0.1

0.23

Body mass index (kg/m²)

23.9 (5.2)

22.4 (4.8)

25.1 (5.2)

<0.001

0.53

Symptomatic stroke

22 ( 9.7)

16 (16.7)

6 (4.6)

0.003

0.39

Chronic heart failure

15 (6.6)

11 (11.5)

4 (3.1)

0.01

0.32

Ischemic heart disease

28 (12.4)

11 (11.5)

17 (13.1)

0.83

0.04

Hypertension

115 (50.9)

55 (57.3)

60 (46.2)

0.1

0.22

Diabetes mellitus

67 (29.6)

24 (25.0)

43 (33.1)

0.23

0.17

Atrial fibrillation

15 (6.6)

8 (8.3)

7 (5.4)

0.42

0.11

Chronic lung disease

47 (20.8)

26 (27.1)

21 (16.2)

0.04

0.26

Chronic kidney disease

36 (15.9)

21 (21.9)

15 (11.5)

0.04

0.26

Hematologic disease

12 (5.3)

10 (10.4)

2 (1.5)

0.005

0.38

Connective tissue disease

15 (6.6)

11 (11.5)

4 (3.1)

0.01

0.32

Hepatic failure

20 (8.8)

12 (12.5)

8 (6.2)

0.1

0.22

Solid cancer

55 (24.3)

40 (41.7)

15 (11.5)

<0.001

0.72

Benzodiazepines before hospitalization

17 (7.5)

7 (7.3)

10 (7.7)

1

0.01

CFS score

5.9 (1.4)

6.4 (0.9)

5.6 (1.6)

<0.001

0.58

SOFA score

8.1 (4.0)

9.9 (4.4)

6.8 (3.2)

<0.001

0.80